Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 327 followers
Latest posts
Last updated about 1 hour ago
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
about 1 hour ago
Agreement offers potential best-in-class targeted protein degrader therapy option for people living...
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting
6 days ago
Filing acceptance, under priority review, based on phase III data showing giredestrant...
Roche to present new data advancing its obesity portfolio at the American Diabetes Association’s 2026 Scientific Sessions
7 days ago
Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its...
Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management
12 days ago
Roche introduces the first comprehensive library of certified healthcare algorithms to support...
Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer
20 days ago
New giredestrant data from the lidERA study on its potential as a...
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
27 days ago
Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with...
Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics
about 1 month ago
PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow...
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
about 1 month ago
New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey...
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
about 2 months ago
Group sales were +6% at constant exchange rates (CER)1, -5% when reported...
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
about 2 months ago
Late-breaking Phase III FENhance 1 and 2 study results showed superiority of...
Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD
about 2 months ago
Phase III METEOROID study met its primary endpoint in patients with myelin...
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
about 2 months ago
Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a...